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BackgroundaaAcute ischemic stroke secondary to aortic dissection (AoD) is challenging in the 
era of thrombolysis owing to the diagnostic difficulty within a narrow time window and the high 
risk of complications.   
Case ReportaaA 64-year-old woman with middle cerebral artery occlusion syndrome admitted 
to the emergency room within intravenous recombinant tissue plasminogen activator (rt-PA) 
time window. Her neurological symptoms improved during thrombolysis, but chest and abdom-
inal pain developed. Repeated history-taking, physical examination, and imaging studies led to 
the timely diagnosis and surgical treatment of AoD, which produced a successful outcome.   
ConclusionsaaClinical suspicion is invaluable for the diagnosis of this rare cause of stroke. 
Considering the stroke mechanism and complications, the risks of thrombolysis might outweigh 
its benefits.  J Clin Neurol 2009;5:49-52
 






Aortic dissection (AoD) is a rare cause of acute ischemic 
stroke. For acute ischemic stroke patients who are eligible 
for thrombolysis, AoD is particularly challenging owing to 
the difficulty of diagnosis within a narrow time window and 
the high risk of life-threatening complications for throm-
bolysis. We report a patient with acute ischemic stroke sec-
ondary to AoD who was treated with intravenous recom-
binant tissue plasminogen activator (rt-PA). Clinical suspicion 
and examination were invaluable for the timely diagnosis and 
treatment. We also review the literature to discuss the risks 




A 69-year-old woman was referred for hemiparesis. At 6:00 
pm, she lost consciousness and was brought to a nearby hos-
pital. She recovered consciousness after 30 minutes, but left-
side hemiparesis was recognized. The results of brain CT were 
unremarkable, and she was transferred to our hospital for 
thrombolysis. 
She arrived at our emergency room 110 minutes after the 
onset. She complained of transient chest discomfort. Concur-
rent acute myocardial infarction was suspected, but her elec-
trocardiogram and cardiac enzymes were normal, and there 
was no cardiac murmur on the initial examination. The neu-
rology stroke team was activated 125 minutes after the onset. 
Her initial National Institutes of Health Stroke Scale 
(NIHSS) score was 6 due to the presence of a visual field 
defect, eyeball deviation, and left hemiparesis. Her blood 
pressure was 140/90 mmHg, and the glucose level and plate-
let count were normal. Review of the brain CT performed in 
the referring hospital revealed no abnormalities. She had no 
contraindications for intravenous rt-PA. During the evalua-





Thrombolysis for Acute Ischemic Stroke Secondary to Aortic Dissection 
  50 J Clin Neurol 2009;5:49-52 
sion of hemiparesis. Since a routine chest X-ray is not re-
commended as an initial evaluation for intravenous rt-PA in 
recent guidelines,
1 this was not performed in order to avoid 
treatment delay before rt-PA treatment. Intravenous rt-PA was 
started 146 minutes after the onset. During treatment, we per-
formed a chest X-ray and then CT angiography to investigate 
the occlusion of large vessels, for which combined intravenous 
and intra-arterial thrombolysis is considered in our protocol. 
Her NIHSS score improved from 8 to 4 during the treat-
ment, but chest and abdominal pain developed. CT angio-
graphy revealed no occlusion in the major intracranial arter-
ies, but her extracranial carotid arteries could not be recon-
structed, probably due to slow flow or a technical problem. 
However, bilateral carotid dissections were suspected on the 
source images (Fig. 1). Mediastinal widening was also sus-
pected on the chest X-ray. A repeated physical examination 
revealed bilaterally diminished pedal pulses and a newly 
developed diastolic murmur. Repeated history-taking revealed 
chest pain, after which she lost consciousness. 
We stopped intravenous rt-PA after infusing 60% of the 
total dose. An urgent chest CT revealed a Stanford type A 
AoD extending to the aortic valve. Emergent aortic surgery 
was started at 10:00 pm. Although the surgery took more than 
10 hours due to the impaired hemostasis, she recovered 
without neurological deficit. Follow-up MRI performed 13 
days postsurgery revealed small high signal intensity lesions 
on diffusion-weighted images, but the intracranial and ex-
tracranial arteries were patent (Fig. 2), and at 3 months her 




AoD is a rare cause of ischemic stroke, but it is challenging 
in the era of thrombolysis owing to the diagnostic difficulty 
Fig. 1. CT angiography revealed no occlusion in the intracranial major arteries (A), but suggested dissection in the bilateral extracranial 
carotid arteries on the source images (B, black arrows). Emergent chest CT showed a Stanford type A aortic dissection (C, white arrows). 
A  B  C
Fig. 2. Follow-up MRI performed 13 
days postsurgery revealed small infarc-
tions (A), but no occlusions in the ex-
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within a narrow time window and the high risk of life-threat-
ening hemorrhagic complications. About 30% of patients with 
Stanford type A dissection show initial neurologic symptoms, 
but one-third of them do not report typical pain. More than 
half of the neurologic symptoms are attributable to acute 
ischemic stroke.
1 As it is not practical to perform the diag-
nostic tests for AoD in every patient who is eligible for throm-
bolysis, clinical suspicion and examination are invaluable. In 
the present case, we should have paid attention to the loss of 
consciousness since this is not a usual presentation of middle 
cerebral artery occlusion. Examination of the peripheral pulse 
might have led to a faster diagnosis. Although a chest X-ray 
is not recommended as a routine initial evaluation before rt-
PA administration in order to avoid treatment delay, it is re-
commended in patients with clinical or other evidence of acute 
cardiac or pulmonary disease,
2 as in the present case. Our case 
also demonstrates the importance of patient monitoring during 
rt-PA treatment. Although a diagnosis was not made before 
rt-PA initiation, we were alert to her clinical changes. Re-
peated history-taking, physical examination, and careful inter-
pretation of CT angiography led to a timely diagnosis and 
surgical treatment. 
It is not clear whether rt-PA is indicated for acute ischemic 
stroke secondary to AoD, especially for patients expected to 
have severe disability without treatment. Current guidelines 
do not state specifically whether this situation is contraindi-
cated for intravenous rt-PA. Surgeons are reluctant to per-
form surgery on AoD patients complicated by acute ischemic 
stroke. However, the outcome of AoD is usually poor without 
surgery. 
Thrombolysis might contribute to dissection extension or 
rupture by interfering with thrombus formation at the intimal 
tear, increasing the risk of early death due to worsening he-
mothorax, or hemopericardium. Thrombolysis can also delay 
surgery and interfere with hemostasis. This issue has been a 
concern in the era of acute myocardial infarction because 
AoD can simulate acute myocardial infarction. The outcome 
of these patients after rt-PA treatment was poor, with a re-
ported mortality of up to 71%.
3 A literature review of the 
stroke field revealed three cases treated with thrombolysis,
1,4,5 
and seven cases given only a loading dose or considered but 
not treated,
6-12 as summarized in Table 1; the mortality rates 
were 75% and 43% in the former and latter cases, respec-
tively. Among the treated patients, one death was attributed to 
cardiac tamponade and intrapleural hemorrhage considered 
to be related to thrombolysis. In the present case, thrombolysis 
could contribute to dissection extension considering the pres-
ence of recurrent dissecting pain and the newly developed 
aortic regurgitation murmur after treatment. Among the pa-
tients considered but not treated or given only a loading dose, 
two out of the three deaths were caused by stroke and pre-
sumed hypoxic brain damage. The outcomes of the survivors 
given only a loading dose or considered but not treated were 
relatively favorable considering their initial stroke severity 
(Table 1). 
The efficacy of thrombolysis should be considered in the 
light of the stroke mechanism in AoD. The most common 
mechanism is mechanical obstruction of the common carotid 
arteries due to the dissection extending to the supra-aortic 
area.
1 Complete occlusion might be resistant to thrombolysis 
because of limited rt-PA delivery to the occlusion site or rt-PA 
not being effective for mechanical occlusion by the intimal 
flap. For partial or transient occlusion, spontaneous reperfu-
sion might be possible without applying a high-risk treatment. 


















Cardiac tamponade and 
intrapleural hemorrhage 
04  54/M  IV rt-PA  Left MCA infarction  No  Dead  Severe ischemic stroke 





rt-PA, only a   
loading dose 











rt-PA, only a   
loading dose 



















Shock and profound   
neurologic deficit 
09  60/F  No  NIHSS score of 14  No  Dead  Aortic rupture 














12  56/F  No  NIHSS score of 18  No  Mild hemiparesis   
Ref: References number, IV: intravenous, MCA: middle cerebral artery, rt-PA: recombinant tissue plasminogen activator, ICA: internal 
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Neurological symptoms were transient in many cases.
1,6,7,10,11 
In our patient the partial obstruction in both carotid arteries 
was confirmed during surgery. However, there is no extension 
of dissection to the supra-aortic area in onethird of patients 
with stroke, in which thromboembolism and/or severe hypo-
tension are considered as possible mechanisms.
1 Therefore, 
thrombolysis for ischemic stroke secondary to AoD might be 
efficacious in the minority of patients with a thromboembolic 
mechanism. 
In conclusion, allowing for the known risks and benefits, 
intravenous rt-PA might not be indicated in most patients 
with acute ischemic stroke secondary to aortic dissection. 
Clinical suspicion and examination are invaluable for diag-
nosing AoD as an etiology of acute ischemic stroke, especially 
when considering the treatment of thrombolysis. 
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